Logo Logo
Mobile Logo
book now
Logo&nsbp;
  • Home
  • Agenda
    • View Web-AgendaSee all the exciting sessions we have in store for you
    • Download Agenda
    • Book Now
  • Speakers
    • PanelFind out which experts are sharing their insights and use cases on Pharma MES USA
    • Become a Speaker
    • Book Now
  • Partners
    • Co-Located Event1 Sponsorship – 3 Targeted Conferences
    • Business PartnersNetwork with our partner community and discover their cutting-edge products & services
    • Why Partner?Connect with the right people in a space designed to optimize your relationship-building and deal-making
    • Matchmaking & One2Ones
    • Get Sponsorship Prospectus
    • Current participants list
    • Past event attendeelist
  • Who & Why?
    • The Event at a glanceWhat can you expect as an Attendee at Pharma MES USA?
    • AttendTop-Level Networking meets Unmatched Expertise
    • 10 reasons to attendWhy you should join
    • TestimonialsWhat our clients say
    • Current participants list
    • Past event attendeelist
  • Event Info
    • Travel & LocationOnsite Location - Join us in Boston!
    • Evening EventsIcebreaker + Networking Dinner
    • Co-Located Event1 Ticket - 4 Events
    • ContactGET IN TOUCH - We are here for you!
    • Global Pharma MES SeriesFind out more about our Global Pharma MES Series
    • Book Now
  • Content Hub
    • Video Case StudiesExplore Our Video Case Studies! Inspirational success stories, technologies, and solutions from our speakers!
    • InterviewsVideo Interviews with Our Speakers! Exciting conversations, insights, and expertise on the latest trends & technologies.
    • Whitepapers & ReportsTrend Reports & Whitepapers! In-depth analyses, industry insights, and expert perspectives on key trends and developments.
    • Book Now
  • EXHIBIT NOW
  • BOOK NOW
CO-LOCATED EVENTS

Speaker

Burkhard Wandelt

Director Engineering & Technology, Merck KGaA

Burkhard has over 30 years of experience in the pharmaceutical and biotech industry. He is currently Director of Engineering & Technology at Merck Serono in Aubonne, Switzerland, where he leads global maintenance and large-scale biotech projects. Previously, he held technical and managerial roles at Pfizer, Sanofi-Aventis, and Hoechst AG.

Join Burkhard Wandelt
Book Now!

Sessions

From Obsolescence to Predictive Intelligence — Advancing Maintenance Management Across Global Sites

Case Study

Monday, March 23

09:55 am - 10:25 am

Live in Everett

Less Details

This presentation explores the transformation of maintenance management within a multinational division, highlighting the shift from siloed, legacy practices toward harmonized, digitally mature systems across countries. Building on lessons from obsolescence management and first-generation deployments of core CMMS platforms, the session demonstrates the progression to a second generation of standardized, predictive approaches. Drawing from a network of 18 sites — employing a “sister-site” model to overcome both inter- and intra-site silos — the case illustrates how harmonization, sensor-driven insights, and generative AI can unlock new levels of operational efficiency, resilience, and knowledge accessibility. It also addresses practical challenges such as integrating predictive maintenance with legacy systems and improving access to critical maintenance knowledge. You will learn how to:

  • Advance from first-generation CMMS deployment to predictive, harmonized maintenance systems across countries.
  • Use sensor and process data to detect anomalies and optimize maintenance strategies, transitioning from reactive to predictive interventions.
  • Break down organizational silos with a sister-site collaboration model and leverage generative AI to improve knowledge retrieval and sharing, even in contexts of restrictive information.
Presentation

The Future of Driving Maintenance Excellence and Empowering Pharmaceutical Success Through the Integration of AI

Panel Discussion

Monday, March 23

06:10 pm - 06:55 pm

Live in Everett

Less Details

In this forward-looking panel, industry experts will discuss how AI is shaping the future of maintenance practices within the pharmaceutical industry. As companies aim to drive operational excellence across global sites, AI is emerging as a critical catalyst for optimizing maintenance strategies—from asset lifecycle management to resource planning and operational support. This panel discussion will delve into how AI can enhance predictive maintenance practices, extend asset lifecycles, improve resource allocation, and support consistent and compliant operations across all sites. Panelists will share insights into their approach, lessons learned, best practices, and the evolving role of AI in achieving maintenance excellence that empowers pharmaceutical success. The following topics will be discussed in the panel:

  • How AI-powered tools can drive maintenance excellence by enabling proactive, precise maintenance practices that maximize asset value and reduce downtime.
  • Integrating AI into asset lifecycle management to extend asset lifespan, optimize replacement strategies, and support effective lifecycle planning across global sites.
  • Enhancing resource planning and allocation with AI by using predictive insights to streamline maintenance schedules, optimize resource distribution, and align workforce capabilities with maintenance needs.
  • Building consistent operational support through AI-driven insights to improve compliance, maintain quality standards, and streamline decision-making across geographically dispersed sites.
Presentation

How Can We Transform Maintenance Management from Siloed, Reactive Practices to Harmonized, Predictive Operations Across Global Sites and Countries?

(4) Transformation Café

Tuesday, March 24

11:00 am - 03:00 pm

Live in Everett

Less Details

  • What are the main barriers in your current maintenance operations — including legacy systems and organizational silos — that prevent harmonization and digital maturity?
  • How could sensor data and process analytics be leveraged to anticipate failures and optimize maintenance strategies across multiple countries?
  • In what ways could cross-site collaboration (e.g., sister-site models) strengthen knowledge sharing, consistency, and operational resilience?
  • How could generative AI or other digital tools support technicians in accessing critical maintenance knowledge efficiently, especially when information is difficult to retrieve?
  • What practical steps and lessons learned from pilot deployments could help integrate predictive maintenance while balancing legacy systems and standardization goals?
Workshop

World Café Harvesting Session

Tuesday, March 24

03:30 pm - 04:05 pm

Live in Everett

Less Details

In the Harvesting Session the World Café moderators will summarize the results of their discussions and highlight key findings.

Presentation

Company

Merck KGaA

Life is a beautiful gift and health is what allows us to enjoy it. That is why we are deeply committed to helping patients. No matter how complex or rare the disease may be, we don‘t give up. Our ~17,800 Healthcare employees wake up every day motivated by our purpose: To help create, improve and prolong lives – as one for patients. We are the Healthcare business of Merck, and the only pharmaceutical company that is developing solutions along the whole “circle of life”. For over 350 years, patients have always been at the heart of everything we do. Our pioneering work in cancer treatment is focused on discovering, developing and delivering science-driven breakthrough therapies that turn cancer patients into cancer survivors. Our tireless passion for R&D as well as a creative and focused approach help accelerate innovation in oncology and immuno-oncology. To realize our ambition, we’ve created a balanced portfolio. Our core business helps provide a strong foundation, fund innovation and mitigate risks. Our specialty portfolio enables us to be on the frontlines of change and truly become a specialty innovator. We have a proud history of advancing care in immunology for people living with chronic progressive diseases such as multiple sclerosis. For more than two decades we have maintained our commitment to delivering innovative solutions across treatment, devices, and support services. This dedication drives the research and development of our pipeline products and our efforts to address areas of unmet medical need. Today, we are a global market leader in the field of fertility treatments. Our therapeutic portfolio, devices and advanced fertility technologies have helped many couples achieve their dream of having a baby. Everyone should have the opportunity to become a parent. To date, more than 5 million babies have been brought into the world with the help of our leading fertility products.
Get Agenda
BOOK NOW
Co-hosted with
Pharma MES USA 2026 is part of the Event Series. You can find more events here.
Date
March 23 – 24, 2026
Location
Encore Boston Harbor
1 Broadway
02149 Everett
Phone
+1(518)3102904
eMail
  • To sponsor
  • To speak
  • Media partnerships
  • General inquiries
© we.CONECT Global Leaders GmbH